C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
530/5.1, 167/103
C07K 5/04 (2006.01) A61K 38/04 (2006.01) C07K 5/10 (2006.01)
Patent
CA 2019006
Disclosed herein are tetrapeptide derivatives of the formula X-NH-CHR1-C(W1)-NR2-CH[CH2C(O)-Y]-C(W2)-NH-CH[CR3(R5)- COON]-C(W3)-NH-CHR5-Z wherein X is a terminal group, for example, alkanoyl or phenylalkanoyl radicals, R1 and R5 are selected from amino acid or derived amino acid residues, R2 is hydrogen, alkyl or phenylalkyl, R3 and R4 are joined to form a cycloalkyl, W1, W2 and W3 are oxo or thioxo, Y is, for example, an alkoxy or a monosubstituted or disubstituted amino, and Z is a terminal unit, for example, hydrogen, COON or CH2OH. The derivatives are useful for treating herpes infections.
Deziel Robert
Moss Neil
Boehringer Ingelheim (canada) Ltd. Boehringer Ingelheim (canada)
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Antiherpes tetrapeptide derivatives having a cycloalkyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiherpes tetrapeptide derivatives having a cycloalkyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiherpes tetrapeptide derivatives having a cycloalkyl... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1919308